ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases
ICD-10 is an international statistical classification used in health care and related industries.
Chapter | Block | Title |
---|---|---|
I | A00–B99 | Certain infectious and parasitic diseases |
II | C00–D48 | Neoplasms |
III | D50–D89 | Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism |
IV | E00–E90 | Endocrine, nutritional and metabolic diseases |
V | F00–F99 | Mental and behavioural disorders |
VI | G00–G99 | Diseases of the nervous system |
VII | H00–H59 | Diseases of the eye and adnexa |
VIII | H60–H95 | Diseases of the ear and mastoid process |
IX | I00–I99 | Diseases of the circulatory system |
X | J00–J99 | Diseases of the respiratory system |
XI | K00–K93 | Diseases of the digestive system |
XII | L00–L99 | Diseases of the skin and subcutaneous tissue |
XIII | M00–M99 | Diseases of the musculoskeletal system and connective tissue |
XIV | N00–N99 | Diseases of the genitourinary system |
XV | O00–O99 | Pregnancy, childbirth and the puerperium |
XVI | P00–P96 | Certain conditions originating in the perinatal period |
XVII | Q00–Q99 | Congenital malformations, deformations and chromosomal abnormalities |
XVIII | R00–R99 | Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
XIX | S00–T98 | Injury, poisoning and certain other consequences of external causes |
XX | V01–Y98 | External causes of morbidity and mortality |
XXI | Z00–Z99 | Factors influencing health status and contact with health services |
XXII | U00–U99 | Codes for special purposes |
Produced by the World Health Organization, it is used in several countries around the world. Some have gone on to develop their own national enhancements, building off the international classification.
Chapter IV of ICD-10 deals with endocrine, nutritional and metabolic diseases.
E00–E35 – Endocrine diseases
(E00–E07) Thyroid gland / Thyroid hormone
- (E00) Congenital iodine-deficiency syndrome
- (E01) Iodine-deficiency-related thyroid disorders and allied conditions
- (E01.0) Iodine-deficiency-related diffuse (endemic) goitre
- (E01.1) Iodine-deficiency-related multinodular (endemic) goitre
- (E01.2) Iodine-deficiency-related (endemic) goitre, unspecified
- (E01.8) Other iodine-deficiency-related thyroid disorders and allied condition
- (E02) Subclinical iodine-deficiency hypothyroidism
- (E03) Other hypothyroidism
- (E03.0) Congenital hypothyroidism with diffuse goitre
- (E03.1) Congenital hypothyroidism without goitre
- (E03.2) Hypothyroidism due to medicaments and other exogenous substances
- (E03.3) Postinfectious hypothyroidism
- (E03.4) Atrophy of thyroid (acquired)
- (E03.5) Myxoedema coma
- (E04) Other nontoxic goitre
- (E05) Thyrotoxicosis (hyperthyroidism)
- (E05.0) Thyrotoxicosis with diffuse goitre
- (E05.1) Thyrotoxicosis with toxic single thyroid nodule
- (E05.2) Thyrotoxicosis with toxic multinodular goitre
- (E05.3) Thyrotoxicosis from ectopic thyroid tissue
- (E05.4) Thyrotoxicosis factitia
- (E05.5) Thyroid crisis or storm
- (E05.8) Other thyrotoxicosis
- (E05.9) Thyrotoxicosis, unspecified
- (E06) Thyroiditis
- (E06.0) Acute thyroiditis
- (E06.1) Subacute thyroiditis
- (E06.2) Chronic thyroiditis with transient thyrotoxicosis
- (E06.3) Autoimmune thyroiditis
- (E06.4) Drug-induced thyroiditis
- (E06.5) Other chronic thyroiditis
- (E06.9) Thyroiditis, unspecified
- (E07) Other disorders of thyroid
(E10–E16) Pancreas / Insulin, glucagon
(E10–E14) Diabetes mellitus
- (E10) Insulin-dependent diabetes mellitus
- (E11) Non-insulin-dependent diabetes mellitus
- (E12) Malnutrition-related diabetes mellitus
- (E13) Other specified diabetes mellitus
- (E14) Unspecified diabetes mellitus
(E15–E16) Other disorders of glucose regulation and pancreatic internal secretion
- (E15) Nondiabetic hypoglycaemic coma
- Drug-induced insulin coma in nondiabetic
- Hyperinsulinism with hypoglycaemic coma
- Hypoglycaemic coma NOS
- (E16) Other disorders of pancreatic internal secretion
- (E16.0) Drug-induced hypoglycaemia without coma
- (E16.1) Other hypoglycaemia
- Functional nonhyperinsulinaemic hypoglycaemia
- Hyperinsulinism: NOS
- Hyperinsulinism: functional
- Hyperplasia of pancreatic islet beta cells NOS
- Posthypoglycaemic coma encephalopathy
- (E16.2) Hypoglycaemia, unspecified
- (E16.3) Increased secretion of glucagon
- (E16.4) Abnormal secretion of gastrin
- Hypergastrinaemia
- Zollinger-Ellison syndrome
- (E16.8) Other specified disorders of pancreatic internal secretion
- (E16.9) Disorder of pancreatic internal secretion, unspecified
(E20–E21) Parathyroid gland / PTH
- (E20) Hypoparathyroidism
- (E21) Hyperparathyroidism and other disorders of parathyroid gland
- (E21.0) Primary hyperparathyroidism
- (E21.1) Secondary hyperparathyroidism, not elsewhere classified
(E22–E23) Pituitary gland / ADH, oxytocin, GH, ACTH, TSH, LH, FSH, prolactin
- (E22) Hyperfunction of pituitary gland
- (E23) Hypofunction and other disorders of pituitary gland
- (E23.0) Hypopituitarism
- Fertile eunuch syndrome
- Hypogonadotropic hypogonadism
- Idiopathic growth hormone deficiency
- Isolated deficiency of gonadotropin
- Isolated deficiency of growth hormone
- Isolated deficiency of pituitary hormone
- Kallmann's syndrome
- Lorain-Levi short stature
- Necrosis of pituitary gland (postpartum)
- Panhypopituitarism
- Pituitary cachexia
- Pituitary insufficiency NOS
- Pituitary short stature
- Sheehan's syndrome
- Simmonds' disease
- (E23.1) Drug-induced hypopituitarism
- (E23.2) Diabetes insipidus
- (E23.3) Hypothalamic dysfunction, not elsewhere classified
- (E23.6) Other disorders of pituitary gland
- Abscess of pituitary
- Adiposogenital dystrophy
- (E23.7) Disorder of pituitary gland, unspecified
- (E23.0) Hypopituitarism
(E24–E27) Adrenal gland / Aldosterone, cortisol, epinephrine, norepinephrine
- (E24) Cushing's syndrome
- (E24.0) Pituitary-dependent Cushing's disease
- (E24.1) Nelson's syndrome
- (E24.2) Ectopic ACTH syndrome
- (E24.3) Alcohol-induced pseudo-Cushing's syndrome
- (E24.4) Other Cushing's syndrome
- (E24.5) Cushing's syndrome, unspecified
- (E25) Adrenogenital disorders
- (E25.0) Congenital adrenogenital disorders associated with enzyme deficiency
- (E26) Hyperaldosteronism
- (E26.0) Primary hyperaldosteronism
- Conn's syndrome
- Primary aldosteronism due to adrenal hyperplasia (bilateral)
- (E26.1) Secondary hyperaldosteronism
- (E26.8) Other hyperaldosteronism
- (E26.9) Hyperaldosteronism, unspecified
- (E26.0) Primary hyperaldosteronism
- (E27) Other disorders of adrenal gland
- (E27.0) Other adrenocortical overactivity
- (E27.1) Primary adrenocortical insufficiency
- (E27.2) Addisonian crisis
- (E27.3) Drug-induced adrenocortical insufficiency
- (E27.4) Other and unspecified adrenocortical insufficiency
- (E27.5) Adrenomedullary hyperfunction
(E28–E30) Gonads / Estrogen, androgens, testosterone, etc.
- (E28) Ovarian dysfunction
- (E28.0) Estrogen excess
- (E28.1) Androgen excess
- (E28.2) Polycystic ovarian syndrome
- (E28.3) Primary ovarian failure
- (E29) Testicular dysfunction
- (E29.0) Testicular hyperfunction
- (E29.1) Testicular hypofunction
- 5-Alpha-reductase deficiency (with male pseudohermaphroditism)
- Testicular hypogonadism NOS
- (E30) Disorders of puberty, not elsewhere classified
- (E30.0) Delayed puberty
- (E30.1) Precocious puberty
- (E30.8) Other disorders of puberty
- Premature thelarche
(E31–E35) Other
- (E31) Polyglandular dysfunction
- (E31.0) Autoimmune polyglandular failure
- (E31.1) Polyglandular hyperfunction
- (E32) Diseases of thymus
- (E34) Other endocrine disorders
- (E34.0) Carcinoid syndrome
- (E34.1) Other hypersecretion of intestinal hormones
- (E34.2) Ectopic hormone secretion, not elsewhere classified
- (E34.3) Short stature, not elsewhere classified
- NOS
- constitutional
- Laron-type
- psychosocial
- (E34.4) Constitutional tall stature
- Constitutional gigantism
- (E34.5) Androgen resistance syndrome
- (E34.8) Other specified endocrine disorders
- (E35) Disorders of endocrine glands in diseases classified elsewhere
- (E35.0) Disorders of thyroid gland in diseases classified elsewhere
- (E35.1) Disorders of adrenal glands in diseases classified elsewhere
- (E35.8) Disorders of other endocrine glands in diseases classified elsewhere
E40–E68 – Nutritional diseases
(E40–E46) Malnutrition
- (E40) Kwashiorkor
- (E41) Nutritional marasmus
- (E42) Marasmic kwashiorkor
- (E43) Unspecified severe protein–energy malnutrition
- (E44) Protein–energy malnutrition of moderate and mild degree
- (E45) Retarded development following protein–energy malnutrition
- (E46) Unspecified protein–energy malnutrition
(E50–E64) Other nutritional deficiencies
- (E50) Vitamin A deficiency
- (E50.0) Vitamin A deficiency with conjunctival xerosis
- (E50.1) Vitamin A deficiency with Bitot's spot and conjunctival xerosis
- (E50.2) Vitamin A deficiency with corneal xerosis
- (E50.3) Vitamin A deficiency with corneal ulceration and xerosis
- (E50.4) Vitamin A deficiency with keratomalacia
- (E50.5) Vitamin A deficiency with night blindness
- (E50.6) Vitamin A deficiency with xerophthalmic scars of cornea
- (E50.7) Other ocular manifestations of vitamin A deficiency
- Xerophthalmia NOS
- (E51) Thiamine deficiency
- (E52) Niacin deficiency (pellagra)
- (E53) Deficiency of other B group vitamins
- (E53.0) Riboflavin deficiency
- (E53.1) Pyridoxine deficiency
- (E53.8) Deficiency of other specified B group vitamins
- (E54) Ascorbic acid deficiency
- (E55) Vitamin D deficiency
- (E56) Other vitamin deficiencies
- (E58) Dietary calcium deficiency
- (E59) Dietary selenium deficiency
- (E60) Dietary zinc deficiency
- (E61) Deficiency of other nutrient elements
- (E61.1) Iron deficiency
- (E61.2) Magnesium deficiency
- (E61.3) Manganese deficiency
- (E61.4) Chromium deficiency
- (E61.5) Molybdenum deficiency
- (E61.6) Vanadium deficiency
- (E63) Other nutritional deficiencies
- (E63.0) Essential fatty acid (EFA) deficiency
- (E64) Sequelae of malnutrition and other nutritional deficiencies
(E65–E68) Obesity and other hyperalimentation
- (E65) Localized adiposity
- (E66) Obesity
- (E67) Other hyperalimentation
- (E67.0) Hypervitaminosis A
- (E67.1) Hypercarotenaemia
- (E67.2) Megavitamin-B 6 syndrome
- (E67.3) Hypervitaminosis D
- (E68) Sequelae of hyperalimentation
E70–E90 – Metabolic diseases
(E70–E78) Metabolic disorders of proteins, fats, and carbohydrates
(E70–E72) Amino-acids
- (E70) Disorders of aromatic amino-acid metabolism
- (E70.0) Classical phenylketonuria
- (E70.1) Other hyperphenylalaninaemias
- (E70.2) Disorders of tyrosine metabolism
- Alkaptonuria (ILDS E70.210)
- Ochronosis (ILDS E70.230)
- Tyrosinaemia
- (E70.3) Albinism
- Oculocutaneous albinism (ILDS E70.310)
- Partial albinism (ILDS E70.312)
- Oculocutaneous albinism type 1 (tyrosinase-negative) (ILDS E70.314)
- Oculocutaneous albinism type 2 (tyrosinase positive) (ILDS E70.314)
- Albinoidism (ILDS E70.318)
- Waardenburg syndrome (ILDS E70.320)
- Chédiak–Higashi syndrome (ILDS E70.340)
- Piebaldism (ILDS E70.350)
- Tietz syndrome (ILDS E70.358)
- Hermansky–Pudlak syndrome (ILDS E70.360)
- Cross syndrome (ILDS E70.380)
- (E70.8) Other disorders of aromatic amino-acid metabolism
- Disorders of histidine metabolism
- Disorders of tryptophan metabolism
- (E70.9) Disorder of aromatic amino-acid metabolism, unspecified
- (E71) Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
- (E71.0) Maple-syrup-urine disease
- (E71.1) Other disorders of branched-chain amino-acid metabolism
- (E71.2) Disorder of branched-chain amino-acid metabolism, unspecified
- (E71.3) Disorders of fatty-acid metabolism
- Adrenoleukodystrophy (Addison-Schilder)
- Muscle carnitine palmityltransferase deficiency
- (E72) Other disorders of amino-acid metabolism
- (E72.0) Disorders of amino-acid transport
- (E72.1) Disorders of sulfur-bearing amino-acid metabolism
- Cystathioninuria
- Homocystinuria
- Methioninaemia
- Sulfite oxidase deficiency
- (E72.2) Disorders of urea cycle metabolism
- Argininaemia
- Argininosuccinic aciduria
- Citrullinaemia
- Hyperammonaemia
- (E72.3) Disorders of lysine and hydroxylysine metabolism
- Glutaric aciduria
- Hydroxylysinaemia
- Hyperlysinaemia
- Lysinuric protein intolerance
- (E72.4) Disorders of ornithine metabolism
- Ornithinaemia (types I, II)
- (E72.5) Disorders of glycine metabolism
- Hyperhydroxyprolinaemia
- Hyperprolinaemia (types I, II)
- Non-ketotic hyperglycinaemia
- Sarcosinaemia
(E73–E74) Carbohydrates
- (E73) Lactose intolerance
- (E74) Other disorders of carbohydrate metabolism
- (E74.0) Glycogen storage disease
- (E74.1) Disorders of fructose metabolism
- (E74.2) Disorders of galactose metabolism
- (E74.3) Other disorders of intestinal carbohydrate absorption
- (E74.4) Disorders of pyruvate metabolism and gluconeogenesis
- Deficiency of phosphoenolpyruvate carboxykinase
- Deficiency of pyruvate carboxylase
- Deficiency of pyruvate dehydrogenase
- (E74.8) Other specified disorders of carbohydrate metabolism
- (E74.9) Disorder of carbohydrate metabolism, unspecified
(E75) Lipids
- (E75) Disorders of sphingolipid metabolism and other lipid storage disorders
- (E75.0) GM 2 gangliosidosis
- (E75.1) Other gangliosidosis
- (E75.2) Other sphingolipidosis
- Gaucher's disease (ILDS E75.220)
- Niemann–Pick disease (ILDS E75.230)
- Farber disease (ILDS E75.240)
- Fabry disease (ILDS E75.250)
- (E75.3) Sphingolipidosis, unspecified
- (E75.4) Neuronal ceroid lipofuscinosis
- Batten disease (Type 3)
- Jansky–Bielschowsky disease (Type 2)
- Kufs disease (Type 4)
- Spielmeyer–Vogt disease (Type 3)
- (E75.5) Other lipid storage disorders
- Cerebrotendinous cholesterosis (van Bogaert–Scherer–Epstein)
- Wolman's disease
- (E75.6) Lipid storage disorder, unspecified
(E76–E78) Combinations
- (E76) Disorders of glycosaminoglycan metabolism
- (E76.0) Mucopolysaccharidosis, type I
- (E76.1) Mucopolysaccharidosis, type II
- (E76.2) Other mucopolysaccharidoses
- (E77) Disorders of glycoprotein metabolism
- (E77.0) Defects in post-translational modification of lysosomal enzymes
- (E77.1) Defects in glycoprotein degradation
- (E77.8) Other disorders of glycoprotein metabolism
- (E77.9) Disorder of glycoprotein metabolism, unspecified
- (E78) Disorders of lipoprotein metabolism and other lipidaemias
- (E78.0) Pure hypercholesterolaemia
- Familial hypercholesterolaemia
- Fredrickson's hyperlipoproteinaemia, type IIa
- Hyperbetalipoproteinaemia
- Hyperlipidaemia, group A
- Low-density-lipoprotein-type (LDL) hyperlipoproteinaemia
- (E78.1) Pure hyperglyceridaemia
- Endogenous hyperglyceridaemia
- Fredrickson's hyperlipoproteinaemia, type IV
- Hyperlipidaemia, group B
- Hyperprebetalipoproteinaemia
- Very-low-density-lipoprotein-type (VLDL) hyperlipoproteinaemia
- (E78.2) Mixed hyperlipidaemia
- Broad- or floating-betalipoproteinaemia
- Fredrickson's hyperlipoproteinaemia, type IIb or III
- Hyperbetalipoproteinaemia with prebetalipoproteinaemia
- Hypercholesterolaemia with endogenous hyperglyceridaemia
- Hyperlipidaemia, group C
- Tubero-eruptive xanthoma
- Xanthoma tuberosum
- (E78.3) Hyperchylomicronaemia
- Fredrickson's hyperlipoproteinaemia, type I or V
- Hyperlipidaemia, group D
- Mixed hyperglyceridaemia
- (E78.4) Other hyperlipidaemia
- (E78.5) Hyperlipidaemia, unspecified
- (E78.6) Lipoprotein deficiency
- Abetalipoproteinaemia
- High-density lipoprotein deficiency
- Hypoalphalipoproteinaemia
- Hypobetalipoproteinaemia (familial)
- Lecithin cholesterol acyltransferase deficiency
- Tangier disease
- (E78.0) Pure hypercholesterolaemia
(E79–E90) Other metabolic disorders
- (E79) Disorders of purine and pyrimidine metabolism
- (E79.0) Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
- (E79.1) Lesch–Nyhan syndrome
- (E79.8) Other disorders of purine and pyrimidine metabolism
- Hereditary xanthinuria
- (E80) Disorders of porphyrin and bilirubin metabolism
- (E80.0) Hereditary erythropoietic porphyria
- Erythropoietic protoporphyria (ILDS E80.010)
- Erythropoietic porphyria, congenital (ILDS E80.020)
- Gunther disease (ILDS (ILDS E80.020)
- Erythropoietic porphyria (ILDS (ILDS E80.030)
- Erythropoietic coproporphyria (ILDS E80.040)
- (E80.1) Porphyria cutanea tarda
- Sporadic porphyria cutanea tarda (ILDS E80.110)
- Familial porphyria cutanea tarda (ILDS E80.120)
- (E80.2) Other porphyria
- Acute intermittent porphyria (ILDS E80.210)
- Hereditary coproporphyria (ILDS E80.222)
- Variegate porphyria (ILDS E80.230)
- Chester porphyria (ILDS E80.232)
- Porphyria, hepatic (ILDS E80.240)
- Pseudoporphyria (ILDS E80.250)
- Toxic porphyria (ILDS E80.260)
- Hepatoerythropoietic porphyria (ILDS E80.282)
- Porphyria, NOS (ILDS E80.290)
- (E80.3) Defects of catalase and peroxidase
- Acatalasia (Takahara)
- (E80.4) Gilbert's syndrome
- (E80.5) Crigler–Najjar syndrome
- (E80.6) Other disorders of bilirubin metabolism
- (E80.7) Disorder of bilirubin metabolism, unspecified
- (E80.0) Hereditary erythropoietic porphyria
- (E83) Disorders of mineral metabolism
- (E83.0) Disorders of copper metabolism
- (E83.1) Disorders of iron metabolism
- (E83.2) Disorders of zinc metabolism
- (E83.3) Disorders of phosphorus metabolism
- Acid phosphatase deficiency
- Familial hypophosphataemia
- Hypophosphatasia
- Vitamin-D-resistant osteomalacia
- Vitamin-D-resistant rickets
- (E83.4) Disorders of magnesium metabolism
- (E83.5) Disorders of calcium metabolism
- Familial hypocalciuric hypercalcaemia
- Idiopathic hypercalciuria
- (E84) Cystic fibrosis
- (E85) Amyloidosis
- (E85.0) Non-neuropathic heredofamilial amyloidosis
- (E85.1) Neuropathic heredofamilial amyloidosis
- Amyloid polyneuropathy (Portuguese)
- (E85.2) Heredofamilial amyloidosis, unspecified
- (E85.3) Secondary systemic amyloidosis
- (E85.4) Organ-limited amyloidosis
- (E85.8) Other amyloidosis
- (E85.9) Amyloidosis, unspecified
- (E86) Volume depletion
- (E87) Other disorders of fluid, electrolyte and acid–base balance
- (E87.0) Hyperosmolality and hypernatraemia
- (E87.1) Hypo-osmolality and hyponatraemia
- (E87.2) Acidosis
- (E87.3) Alkalosis
- (E87.4) Mixed disorder of acid–base balance
- (E87.5) Hyperkalaemia
- (E87.6) Hypokalaemia
- (E87.7) Fluid overload
- (E87.8) Other disorders of electrolyte and fluid balance, not elsewhere classified
- (E88) Other metabolic disorders
- (E88.0) Disorders of plasma-protein metabolism, not elsewhere classified
- Alpha-1-antitrypsin deficiency
- Bisalbuminaemia
- (E88.1) Lipodystrophy, not elsewhere classified
- (E88.2) Lipomatosis, not elsewhere classified
- (E88.8) Other specified metabolic disorders
- Launois–Bensaude adenolipomatosis
- Trimethylaminuria
- (E88.9) Metabolic disorder, unspecified
- (E88.0) Disorders of plasma-protein metabolism, not elsewhere classified
- (E89) Postprocedural endocrine and metabolic disorders, not elsewhere classified
- (E89.0) Postprocedural hypothyroidism
- (E89.1) Postprocedural hypoinsulinaemia
- (E89.2) Postprocedural hypoparathyroidism
- (E89.3) Postprocedural hypopituitarism
- (E89.4) Postprocedural ovarian failure
- (E89.5) Postprocedural testicular hypofunction
- (E89.6) Postprocedural adrenocortical(-medullary) hypofunction
- (E90) Nutritional and metabolic disorders in diseases classified elsewhere
Excludes
- Autoimmune disease (systemic) NOS (M35.9)
- Certain conditions originating in the perinatal period (P00-P96)
- Complications of pregnancy, childbirth and the puerperium (O00-O9A)
- Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- Human immunodeficiency virus [HIV] disease (B20)
- Injury, poisoning and certain other consequences of external causes (S00-T88)
- Neoplasms (C00-D49)
- Symptoms, signs, and abnormal clinical and laboratory findings, NEC (R00-R94)
See also
References
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.